Main
>
ONCOLOGY (**)
>
Lymphoma>NHL>B-Cell>MCL R/R
>
TREAT.:
>
CN. I. BTK Inh.
CN. I. BTK Inh.'s subsections
(*) CN Approval Date: 2020. 12.25
(*) SG Approval Date: 2022. 11.22
Company
Generic Name
Patent>CN Patent Numbers
Patent>SG Patent Numbers
Patent>USA Patent Numbers
TM
CN. I. BTK Inh.'s products
This section has no products
(*) CN Approval Date: 2020. 12.25
(*) SG Approval Date: 2022. 11.22
Company
Generic Name
Patent>CN Patent Numbers
Patent>SG Patent Numbers
Patent>USA Patent Numbers
TM